SGLT2 inhibitors and sleep apnea; how helpful are the medications: A meta-analysis
Background: Sleep disordered breathing (SDB) has a close association with diabetes, especially in obese patients. The use of sodium-glucose co-transporter-2 (SGLT2) inhibitors in patients with diabetes with SDB is a debate with conflicting evidence. We aim to study the effect of SGLT2 inhibitors on...
Main Authors: | Tanveer Mir, Hassan Bin Atique, Neelambuj Regmi, Yasar Sattar, Saira Sundus, Sabah Ambreen, Prateek Lohia, Waqas T. Qureshi, Ayman Soubani |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Endocrine and Metabolic Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666396121000078 |
Similar Items
-
Obstructive sleep apnea-hypopnea syndrome: Etiology and diagnosis
by: Abdul Ghani Sankri-Tarbichi
Published: (2012-01-01) -
The interrelationship between central sleep apnea and atrial fibrillation
by: Lee, Deborah
Published: (2020) -
Laryngomalacia, GER, and sleep apnea are BRUEing – Sometimes!
by: David Gozal
Published: (2021-06-01) -
The Association between Temporomandibular Disorder and Sleep Apnea—A Nationwide Population-Based Cohort Study
by: Ju-Hui Wu, et al.
Published: (2020-08-01) -
Is obstructive sleep apnea a tobacco induced disease?
by: Oana Cristina Arghir, et al.
Published: (2017-05-01)